153 related articles for article (PubMed ID: 11346733)
41. Oral lesions and immune reconstitution syndrome in HIV+/AIDS patients receiving highly active antiretroviral therapy. Epidemiological evidence.
Gaitan Cepeda LA; Ceballos Salobreña A; López Ortega K; Arzate Mora N; Jiménez Soriano Y
Med Oral Patol Oral Cir Bucal; 2008 Feb; 13(2):E85-93. PubMed ID: 18223535
[TBL] [Abstract][Full Text] [Related]
42. Immunological and virological responses to highly active antiretroviral therapy in a non-clinical trial setting in a developing Caribbean country.
Kilaru KR; Kumar A; Sippy N; Carter AO; Roach TC
HIV Med; 2006 Mar; 7(2):99-104. PubMed ID: 16420254
[TBL] [Abstract][Full Text] [Related]
43. Oral manifestations related to immunosuppression degree in HIV-positive children.
Santos LC; Castro GF; de Souza IP; Oliveira RH
Braz Dent J; 2001; 12(2):135-8. PubMed ID: 11450684
[TBL] [Abstract][Full Text] [Related]
44. The relationships between ethnicity, sex, risk group, and virus load in human immunodeficiency virus type 1 antiretroviral-naive patients.
Saul J; Erwin J; Sabin CA; Kulasegaram R; Peters BS
J Infect Dis; 2001 May; 183(10):1518-21. PubMed ID: 11319688
[TBL] [Abstract][Full Text] [Related]
45. Suppression of human immunodeficiency virus type 1 viral load with selenium supplementation: a randomized controlled trial.
Hurwitz BE; Klaus JR; Llabre MM; Gonzalez A; Lawrence PJ; Maher KJ; Greeson JM; Baum MK; Shor-Posner G; Skyler JS; Schneiderman N
Arch Intern Med; 2007 Jan; 167(2):148-54. PubMed ID: 17242315
[TBL] [Abstract][Full Text] [Related]
46. Decrease in hospitalization and mortality rates among children with perinatally acquired HIV type 1 infection receiving highly active antiretroviral therapy.
Viani RM; Araneta MR; Deville JG; Spector SA
Clin Infect Dis; 2004 Sep; 39(5):725-31. PubMed ID: 15356789
[TBL] [Abstract][Full Text] [Related]
47. Oral lesions as predictors of highly active antiretroviral therapy failure in Brazilian HIV-infected children.
Miziara ID; Weber R
J Oral Pathol Med; 2008 Feb; 37(2):99-106. PubMed ID: 18197855
[TBL] [Abstract][Full Text] [Related]
48. Effect of prolonged HAART on oral colonization with Candida and candidiasis.
Yang YL; Lo HJ; Hung CC; Li Y
BMC Infect Dis; 2006 Jan; 6():8. PubMed ID: 16423306
[TBL] [Abstract][Full Text] [Related]
49. Oral candidiasis as a clinical marker related to viral load, CD4 lymphocyte count and CD4 lymphocyte percentage in HIV-infected patients.
Campo J; Del Romero J; Castilla J; García S; Rodríguez C; Bascones A
J Oral Pathol Med; 2002 Jan; 31(1):5-10. PubMed ID: 11896816
[TBL] [Abstract][Full Text] [Related]
50. Risk factors for HIV-related orofacial soft-tissue manifestations in children.
Ramos-Gomez FJ; Hilton JF; Canchola AJ; Greenspan D; Greenspan JS; Maldonado YA
Pediatr Dent; 1996; 18(2):121-6. PubMed ID: 8710713
[TBL] [Abstract][Full Text] [Related]
51. Oral soft tissue manifestations and CD4 lymphocyte counts in HIV-infected children.
Howell RB; Jandinski JJ; Palumbo P; Shey Z; Houpt MI
Pediatr Dent; 1996; 18(2):117-20. PubMed ID: 8710712
[TBL] [Abstract][Full Text] [Related]
52. HIV infection: oral lesions, CD4+ cell count and viral load in an Italian study population.
Margiotta V; Campisi G; Mancuso S; Accurso V; Abbadessa V
J Oral Pathol Med; 1999 Apr; 28(4):173-7. PubMed ID: 10235371
[TBL] [Abstract][Full Text] [Related]
53. Oral candidosis as a clinical marker of immune failure in patients with HIV/AIDS on HAART.
Gaitán-Cepeda LA; Martínez-González M; Ceballos-Salobreña A
AIDS Patient Care STDS; 2005 Feb; 19(2):70-7. PubMed ID: 15716638
[TBL] [Abstract][Full Text] [Related]
54. Oral lesions among HIV-infected hemophiliacs. A study of 54 patients.
Ficarra G; Chiodo M; Morfini M; Longo G; Orsi A; Piluso S; Rafanelli D
Haematologica; 1994; 79(2):148-53. PubMed ID: 8063262
[TBL] [Abstract][Full Text] [Related]
55. Candida-specific systemic cell-mediated immune reactivities in human immunodeficiency virus-positive persons with mucosal candidiasis.
Leigh JE; Barousse M; Swoboda RK; Myers T; Hager S; Wolf NA; Cutright JL; Thompson J; Sobel JD; Fidel PL
J Infect Dis; 2001 Jan; 183(2):277-285. PubMed ID: 11120933
[TBL] [Abstract][Full Text] [Related]
56. Prevalence of oral mucosal lesions and related factors in 200 HIV+/AIDS Iranian patients.
Khatibi M; Moshari AA; Jahromi ZM; Ramezankhani A
J Oral Pathol Med; 2011 Sep; 40(8):659-64. PubMed ID: 21342272
[TBL] [Abstract][Full Text] [Related]
57. Oral colonization by Candida species in AIDS pediatric patients.
Domaneschi C; Massarente DB; de Freitas RS; de Sousa Marques HH; Paula CR; Migliari DA; Antunes JL
Oral Dis; 2011 May; 17(4):393-8. PubMed ID: 21114590
[TBL] [Abstract][Full Text] [Related]
58. Oral health-related quality of life among low-income adults living with HIV.
Tomar SL; Pereyra M; Metsch LR
J Public Health Dent; 2011; 71(3):241-7. PubMed ID: 21972465
[TBL] [Abstract][Full Text] [Related]
59. Effect of CD4+ lymphocyte count, viral load, and duration of taking anti-retroviral treatment on presence of oral lesions in a sample of South African children with HIV+/AIDS.
Duggal MS; Abudiak H; Dunn C; Tong HJ; Munyombwe T
Eur Arch Paediatr Dent; 2010 Oct; 11(5):242-6. PubMed ID: 20932399
[TBL] [Abstract][Full Text] [Related]
60. Oral manifestations in 70 German HIV-infected women.
Schmidt-Westhausen A; Grünewald T; Reichart PA; Pohle HD
Oral Dis; 1997 May; 3 Suppl 1():S28-30. PubMed ID: 9456652
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
